GRAPHEX GROUP LTD-SPON ADR (GRFX)

US38867H1041 - ADR

0.204  +0 (+2%)

After market: 0.2 0 (-1.96%)

Fundamental Rating

1

Taking everything into account, GRFX scores 1 out of 10 in our fundamental rating. GRFX was compared to 81 industry peers in the Professional Services industry. Both the profitability and financial health of GRFX have multiple concerns. GRFX has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GRFX has reported negative net income.
In the past year GRFX has reported a negative cash flow from operations.
In the past 5 years GRFX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: GRFX reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -14.69%, GRFX is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
GRFX has a worse Return On Equity (-37.45%) than 84.62% of its industry peers.
Industry RankSector Rank
ROA -14.69%
ROE -37.45%
ROIC N/A
ROA(3y)-8.67%
ROA(5y)-7.86%
ROE(3y)-25.35%
ROE(5y)-31.08%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GRFX has a Gross Margin (32.92%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GRFX has declined.
The Profit Margin and Operating Margin are not available for GRFX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.35%
GM growth 5Y-10.53%

More info and screens

1

2. Health

2.1 Basic Checks

GRFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRFX has been increased compared to 1 year ago.
GRFX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GRFX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.89, we must say that GRFX is in the distress zone and has some risk of bankruptcy.
GRFX has a Altman-Z score of -0.89. This is amonst the worse of the industry: GRFX underperforms 88.46% of its industry peers.
GRFX has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
GRFX has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: GRFX outperforms 56.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -0.89
ROIC/WACCN/A
WACC4.91%

2.3 Liquidity

GRFX has a Current Ratio of 0.73. This is a bad value and indicates that GRFX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.73, GRFX is not doing good in the industry: 89.74% of the companies in the same industry are doing better.
GRFX has a Quick Ratio of 0.73. This is a bad value and indicates that GRFX is not financially healthy enough and could expect problems in meeting its short term obligations.
GRFX has a Quick ratio of 0.69. This is amonst the worse of the industry: GRFX underperforms 91.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.69

More info and screens

1

3. Growth

3.1 Past

GRFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.39%.
The Revenue for GRFX has decreased by -28.84% in the past year. This is quite bad
GRFX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)-91.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.94%
Revenue 1Y (TTM)-28.84%
Revenue growth 3Y-9.11%
Revenue growth 5Y8.15%
Sales Q2Q%-38.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRFX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GRFX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GRAPHEX GROUP LTD-SPON ADR

NYSEARCA:GRFX (12/23/2024, 8:09:00 PM)

After market: 0.2 0 (-1.96%)

0.204

+0 (+2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-30 2023-08-30
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change2.97%
Ins Owners20.13%
Ins Owner ChangeN/A
Market Cap11.97M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.51
BVpS0.72
TBVpS-0.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.69%
ROE -37.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.92%
FCFM N/A
ROA(3y)-8.67%
ROA(5y)-7.86%
ROE(3y)-25.35%
ROE(5y)-31.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.35%
GM growth 5Y-10.53%
F-Score2
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.59%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.69
Altman-Z -0.89
F-Score2
WACC4.91%
ROIC/WACCN/A
Cap/Depr(3y)2.06%
Cap/Depr(5y)8.4%
Cap/Sales(3y)0.36%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.84%
Revenue growth 3Y-9.11%
Revenue growth 5Y8.15%
Sales Q2Q%-38.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-184.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-587.84%
OCF growth 3YN/A
OCF growth 5YN/A